DNA methyltransferases in hematological malignancies

Alizadeh, 2000, Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature, 403, 503, 10.1038/35000501 Amara, 2010, DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas, Cancer Sci., 101, 1722, 10.1111/j.1349-7006.2010.01569.x Ammerpohl, 2012, Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes, Leukemia, 26, 185, 10.1038/leu.2011.194 Arab, 2019, GADD45A binds R-loops and recruits TET1 to CpG island promoters, Nat. Genet., 51, 217, 10.1038/s41588-018-0306-6 Avery, 1995, Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a desoxyribonucleic acid fraction isolated from Pneumococcus type III. 1944, Mol. Med., 1, 344, 10.1007/BF03401572 Barreto, 2007, Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation, Nature, 445, 671, 10.1038/nature05515 Barwick, 2018, B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation, Nat. Commun., 9, 1900, 10.1038/s41467-018-04234-4 Baubec, 2015, Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation, Nature, 520, 243, 10.1038/nature14176 Bestor, 1988, Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells: the carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases, J. Mol. Biol., 203, 971, 10.1016/0022-2836(88)90122-2 Bestor, 1992, Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain, EMBO J., 11, 2611, 10.1002/j.1460-2075.1992.tb05326.x Bestor, 1983, Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA, Proc. Natl. Acad. Sci. U. S. A., 80, 5559, 10.1073/pnas.80.18.5559 Bestor, 1985, Growth-dependent expression of multiple species of DNA methyltransferase in murine erythroleukemia cells, Proc. Natl. Acad. Sci. U. S. A., 82, 2674, 10.1073/pnas.82.9.2674 Bishop, 1987, A randomized trial of high dose cyclophosphamide, vincristine, and prednisone plus or minus doxorubicin (CVP versus CAVP) with long-term follow-up in advanced non-Hodgkin’s lymphoma, Leukemia, 1, 508 Brunetti, 2017, DNMT3A in leukemia, Cold Spring Harb. Perspect. Med., 7, a030320, 10.1101/cshperspect.a030320 Caiado, 2019, Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection, Nat. Commun., 10, 4986, 10.1038/s41467-019-12983-z Carrier, 1999, Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin, Mol. Cell Biol., 19, 1673, 10.1128/MCB.19.3.1673 Chambwe, 2014, Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes, Blood, 123, 1699, 10.1182/blood-2013-07-509885 Chiappinelli, 2015, Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses, Cell, 162, 974, 10.1016/j.cell.2015.07.011 Christman, 2002, 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy, Oncogene, 21, 5483, 10.1038/sj.onc.1205699 Clozel, 2013, Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma, Cancer Discov., 3, 1002, 10.1158/2159-8290.CD-13-0117 De, 2013, Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity, PLoS Genet., 9, e1003137, 10.1371/journal.pgen.1003137 Di Croce, 2002, Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor, Science, 295, 1079, 10.1126/science.1065173 Ding, 2012, Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing, Nature, 481, 506, 10.1038/nature10738 Dominguez, 2015, DNA methylation dynamics of germinal center B cells are mediated by AID, Cell Rep., 12, 2086, 10.1016/j.celrep.2015.08.036 Dong, 2001, Structure of human DNMT2, an enigmatic DNA methyltransferase homolog that displays denaturant-resistant binding to DNA, Nucleic Acids Res., 29, 439, 10.1093/nar/29.2.439 Duy, 2019, Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML, Cancer Discov., 9, 872, 10.1158/2159-8290.CD-19-0106 Eads, 2002, Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in ApcMin/+ Dnmt1-hypomorphic mice. Epigenetics Chromatin 5, 62, 1296 Edwards, 2017, DNA methylation and DNA methyltransferases, Epigenetics Chromatin, 10, 23, 10.1186/s13072-017-0130-8 El Marabti, 2018, The cancer spliceome: reprograming of alternative splicing in cancer, Front. Mol. Biosci., 5, 80, 10.3389/fmolb.2018.00080 Fried, 2012, Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia, Haematologica, 97, 246, 10.3324/haematol.2011.051581 Frommer, 1992, A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands, Proc. Natl. Acad. Sci. U. S. A., 89, 1827, 10.1073/pnas.89.5.1827 Fuks, 2000, DNA methyltransferase Dnmt1 associates with histone deacetylase activity, Nat. Genet., 24, 88, 10.1038/71750 Fuks, 2001, Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription, EMBO J., 20, 2536, 10.1093/emboj/20.10.2536 Gams, 1985, Phase III study of BCOP v CHOP in unfavorable categories of malignant lymphoma: a Southeastern Cancer Study Group trial, J. Clin. Oncol., 3, 1188, 10.1200/JCO.1985.3.9.1188 Goll, 2006, Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2, Science, 311, 395, 10.1126/science.1120976 Gordon, 1992, Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin’s lymphoma, New Engl. J. Med., 327, 1342, 10.1056/NEJM199211053271903 Grossmann, 2013, The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL, Genes Chromosomes Cancer, 52, 410, 10.1002/gcc.22039 Gruenbaum, 1982, Substrate and sequence specificity of a eukaryotic DNA methylase, Nature, 295, 620, 10.1038/295620a0 Guo, 2015, Structural insight into autoinhibition and histone H3-induced activation of DNMT3A, Nature, 517, 640, 10.1038/nature13899 Ha, 2011, Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery, Hum. Mol. Genet., 20, 126, 10.1093/hmg/ddq451 Haney, 2016, Dnmt3a is a haploinsufficient tumor suppressor in CD8+ peripheral T cell lymphoma, PLoS Genet., 12, 10.1371/journal.pgen.1006334 Hata, 2002, Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice, Development, 129, 983, 10.1242/dev.129.8.1983 Hermann, 2003, The human Dnmt2 has residual DNA-(cytosine-C5) methyltransferase activity, J. Biol. Chem., 278, 31717, 10.1074/jbc.M305448200 Hollander, 2002, Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a, Oncogene, 21, 6228, 10.1038/sj.onc.1205774 Holz-Schietinger, 2011, Oligomerization of DNMT3A controls the mechanism of de Novo DNA methylation, J. Biol. Chem., 286, 41479, 10.1074/jbc.M111.284687 Holz-Schietinger, 2012, Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation, J. Biol. Chem., 287, 30941, 10.1074/jbc.M112.366625 Jeltsch, 2016, Allosteric control of mammalian DNA methyltransferases – a new regulatory paradigm, Nucleic Acids Res., 44, 8556, 10.1093/nar/gkw723 Jia, 2007, Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation, Nature, 449, 248, 10.1038/nature06146 Jia, 2007, Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation, Nature, 449, 248, 10.1038/nature06146 Jones, 1979, Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest oncology group study, Cancer, 43, 417, 10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I Jones, 2019, Epigenetic therapy in immune-oncology, Nat. Rev. Cancer, 19, 151, 10.1038/s41568-019-0109-9 Jurkowska, 2011, Oligomerization and binding of the Dnmt3a DNA methyltransferase to parallel DNA molecules: heterochromatic localization and role of Dnmt3L, J. Biol. Chem., 286, 24200, 10.1074/jbc.M111.254987 Koya, 2016, DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation, Nat. Commun., 7, 10924, 10.1038/ncomms10924 Kreso, 2013, Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer, Science, 339, 543, 10.1126/science.1227670 Küppers, 2009, The biology of Hodgkin's lymphoma, Nat. Rev. Canc., 9, 15, 10.1038/nrc2542 Lai, 2013, DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activation, Genome Res., 23, 2030, 10.1101/gr.155473.113 Landau, 2014, Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia, Cancer Cell, 26, 813, 10.1016/j.ccell.2014.10.012 Lee, 2012, GADD45α inhibition of DNMT1 dependent DNA methylation during homology directed DNA repair, Nucleic Acids Res., 40, 2481, 10.1093/nar/gkr1115 Lei, 1996, De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells, Development, 122, 3195, 10.1242/dev.122.10.3195 Lenz, 2010, Aggressive lymphomas, New Engl. J. Med., 362, 1417, 10.1056/NEJMra0807082 Leonard, 2011, Epigenetic and transcriptional changes which follow epstein-barr virus infection of germinal center B cells and their relevance to the pathogenesis of hodgkin’s lymphoma, J. Virol., 85, 9568, 10.1128/JVI.00468-11 Leonhardt, 1992, A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei, Cell, 71, 865, 10.1016/0092-8674(92)90561-P Lev Maor, 2015, The alternative role of DNA methylation in splicing regulation, Trends Genet., 31, 274, 10.1016/j.tig.2015.03.002 Ley, 2010, DNMT3A mutations in acute myeloid leukemia, New Engl. J. Med., 363, 2424, 10.1056/NEJMoa1005143 Li, 1992, Targeted mutation of the DNA methyltransferase gene results in embryonic lethality, Cell, 69, 915, 10.1016/0092-8674(92)90611-F Li, 2016, Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia, Nat. Med., 22, 792, 10.1038/nm.4125 Liu, 2016, Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine, Proc. Natl. Acad. Sci. U. S. A., 113, 10238, 10.1073/pnas.1612262113 Lyko, 2018, The DNA methyltransferase family: a versatile toolkit for epigenetic regulation, Nat. Rev. Genet., 19, 81, 10.1038/nrg.2017.80 Maes, 2014, The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma, Oncotarget, 5, 3115, 10.18632/oncotarget.1821 Manoharan, 2015, De novo DNA methyltransferases Dnmt3a and Dnmt3b regulate the onset of Igκ light chain rearrangement during early B-cell development, Eur. J. Immunol., 45, 2343, 10.1002/eji.201445035 McCarty, 1946, Studies on the chemical nature of the substance inducing transformation of pneumococcal types, J. Exp. Med., 83, 89, 10.1084/jem.83.2.89 Meissner, 2005, Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis, Nucleic Acids Res., 33, 5868, 10.1093/nar/gki901 Molavi, 2013, Gene methylation and silencing of SOCS3 in mantle cell lymphoma, Br. J. Haematol., 161, 348, 10.1111/bjh.12262 Momparler, 2005, Epigenetic therapy of cancer with 5-Aza-2′-deoxycytidine (decitabine), Semin. Oncol., 32, 443, 10.1053/j.seminoncol.2005.07.008 Moore, 2013, DNA methylation and its basic function, Neuropsychopharmacology, 38, 23, 10.1038/npp.2012.112 Negrotto, 2012, CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors, Leukemia, 26, 244, 10.1038/leu.2011.207 Okano, 1999, DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development, Cell, 99, 247, 10.1016/S0092-8674(00)81656-6 Okano, 1998, Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases, Nat. Genet., 19, 219, 10.1038/890 Palii, 2008, DNA methylation inhibitor 5-Aza-2’-Deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B, Mol. Cell. Biol., 28, 752, 10.1128/MCB.01799-07 Paronetto, 2016, Alternative splicing and cell survival: from tissue homeostasis to disease, Cell Death Differ., 23, 1919, 10.1038/cdd.2016.91 Poole, 2017, DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma, Oncotarget, 8, 76898, 10.18632/oncotarget.20176 Qiu, 2010, Equitoxic doses of 5-Azacytidine and 5-Aza-2′-deoxycytidine induce diverse immediate and overlapping heritable changes in the transcriptome, PLoS One, 5, 10.1371/journal.pone.0012994 Ren, 2018, Structural basis of DNMT1 and DNMT3A-mediated DNA methylation, Genes, 9, 620, 10.3390/genes9120620 Rinaldi, 2016, Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis, Cell Stem Cell, 19, 491, 10.1016/j.stem.2016.06.020 Robaina, 2015, Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis, Exp. Mol. Pathol., 98, 200, 10.1016/j.yexmp.2015.03.006 Roller, 2013, Landmark analysis of DNMT3A mutations in hematological malignancies, Leukemia, 27, 1573, 10.1038/leu.2013.65 Roulois, 2015, DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts, Cell, 162, 961, 10.1016/j.cell.2015.07.056 Rui, 2011, Malignant pirates of the immune system, Nat. Immunol., 12, 933, 10.1038/ni.2094 Russler-Germain, 2014, The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers, Cancer Cell, 25, 442, 10.1016/j.ccr.2014.02.010 Sandoval, 2019, Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners, J. Biol. Chem., 294, 4898, 10.1074/jbc.RA118.006795 Schubert, 2003, Many paths to methyltransfer: a chronicle of convergence, Trends Biochem. Sci., 28, 329, 10.1016/S0968-0004(03)00090-2 Scott, 2006, 5-Aza-2′-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation, Leuk. Res., 30, 69, 10.1016/j.leukres.2005.05.010 Shaknovich, 2011, DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation, Blood, 118, 3559, 10.1182/blood-2011-06-357996 Spencer, 2009, Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis, Nature, 459, 428, 10.1038/nature08012 Stelling, 2019, Pharmacological DNA demethylation restores SMAD1 expression and tumor suppressive signaling in diffuse large B-cell lymphoma, Blood Adv., 3, 3020, 10.1182/bloodadvances.2019000210 Suzuki, 2006, Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b, Oncogene, 25, 2477, 10.1038/sj.onc.1209272 Swerev, 2017, Activation of oncogenic pathways in classical Hodgkin lymphoma by decitabine: a rationale for combination with small molecular weight inhibitors, Int. J. Oncol., 50, 555, 10.3892/ijo.2016.3827 Tamm, 2005, Decitabine activates specific caspases downstream of p73 in myeloid leukemia, Ann. Hematol., 84, 47, 10.1007/s00277-005-0013-0 Teater, 2018, AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis, Nat. Commun., 9, 222, 10.1038/s41467-017-02595-w Wakita, 2013, Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia, Leukemia, 27, 1044, 10.1038/leu.2012.317 Wang, 2018, Aberrant RNA splicing in cancer and drug resistance, Cancers, 10, 458, 10.3390/cancers10110458 Weber, 1994, Cancer Res. 54, 1766 Webster, 2005, Meiotic and epigenetic defects in Dnmt3L-knockout mouse spermatogenesis, Proc. Natl. Acad. Sci. U. S. A., 102, 4068, 10.1073/pnas.0500702102 Weinberg, 2019, The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape, Nature, 573, 281, 10.1038/s41586-019-1534-3 Xie, 2015, The histological classification of diffuse large B-cell lymphomas, Semin. Hematol., 52, 57, 10.1053/j.seminhematol.2015.01.006 Yang, 2015, DNMT3A in haematological malignancies, Nat. Rev. Cancer, 15, 152, 10.1038/nrc3895 Yang, 2014, Gene body methylation can alter gene expression and is a therapeutic target in cancer, Cancer Cell, 26, 577, 10.1016/j.ccr.2014.07.028 Yu, 2018, DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine, J. Clin. Invest., 128, 2376, 10.1172/JCI97924 Zhang, 2005, STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes, Proc. Natl. Acad. Sci. U. S. A., 102, 6948, 10.1073/pnas.0501959102 Zhang, 2019, Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma, Sci. Transl. Med., 11, 10.1126/scitranslmed.aau1167 Zhang, 2017, Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes, Am. J. Transl. Res., 9, 454 Zhao, 2019, BCL2 amplicon loss and transcriptional remodeling drives ABT-199 resistance in B cell lymphoma models, Cancer Cell, 35, 752, 10.1016/j.ccell.2019.04.005 Zhu, 2015, STAT3 signaling pathway is involved in decitabine induced biological phenotype regulation of acute myeloid leukemia cells, Am. J. Transl. Res., 7, 1896